Despite its promise, immunotherapy has several limitations. Not all patients respond to these treatments, and some may experience severe side effects. Furthermore, the high cost of immunotherapy can be a barrier to access. Research is ongoing to find biomarkers that predict response to immunotherapy and to develop strategies to overcome resistance.
